Clinical Practice Guideline on the Evaluation and Follow-up Care of Living Kidney Donors: Public Review
Over the past 2 years the KDIGO Living Kidney Donor Work Group, along with assistance from the Minneapolis VA Center Evidence Review Team, has developed the attached Clinical Practice Guideline on the Evaluation and Follow-up Care of Living Kidney Donors. The goal of this document is to provide guidance for the evaluation and follow-up care of living kidney donors worldwide. We ask that you review this guideline and give us your candid comments and suggestions. Based on your input, we will prepare a final revised version for publication.
We recognize that your time is limited, so feel free to restrict your review and comments to areas of your expertise. Of course, you may review the document in its entirety and all comments are welcomed. We kindly request that you submit your feedback no later than Friday, December 18th to Amit.Garg@lhsc.on.ca
Visit the Living Donor Public Review webpage and submit your comments http://kdigo.org/home/guidelines/livingdonor/
By agreeing to provide feedback on this draft guideline document, you hereby permit KDIGO to acknowledge your participation as a reviewer in the final publication.
Thank you in advance for your time and support. We look forward to hearing from you.
During the 2011 Annual Meeting of the Canadian Society of Transplantation, Health Canada (HC) hosted a workshop about monitoring the safety of organs for transplantation in Canada. Participants in the workshop suggested the creation of a Canadian network to share organ transplant safety information (report available at http://www.cst-transplant.ca/resources-for-health-professionals.html).
In the second issue of the OTSN Newsletter, we will cover some recent developments in organ transplant safety:
1) A Canadian Survey on using Increased Infectious Risk Donors
2) Recent legislation in the United States on the use of HIV positive organs to HIV positive donors.
3) Case of a Pseudomonas transmission to two kidney recipients.
For further information on adverse event reporting contact the Canada Vigilance Program [email@example.com]. For more information on the OTSN, or to get on the mailout list, contact Dr. Deepali Kumar [firstname.lastname@example.org]
National Institute for Nanotechnology (NINT) + Faculty of Medicine (UofA) Research Day
Place: NINT Taylor Seminar Room, NINT Building
Time: 9:30 – Opening remarks
Objective: To bring together researchers at NINT and Faculty of Medicine and to facilitate discussions, exchange of ideas and possibly establish new collaborations.
Registration: please register for free at www. eventbrite.ca
Organ Donation in the Context of Physician Assisted Dying
Jennifer Chandler, University of Ottawa
November 24th, 2015
Faculty of Law McLennan Ross Hall (Rooms 231/237)
The Supreme Court of Canada’s recent unanimous ruling in Carter v. Canada found that physician assisted death (PAD) is permissible for “a competent adult person who (1) clearly consents to the termination of life and (2) has a grievous and irremediable medical condition (including an illness, disease or disability) that causes enduring suffering that is intolerable to the individual in the circumstances of his or her condition.” The ruling opens the door for the possibility of organ donation (OD) after PAD. Cases of this type are likely to be rare, but it is also likely that a patient will eventually make this request. While countries such as Belgium have some experience with OD after PAD, the combined practice is ethically contentious and its potential application in a Canadian context has yet to be explored.
Jennifer Chandler, B.Sc. (Biology) (University of Western Ontario), LL.B. (Queen’s University), LL.M. (Harvard), joined the University of Ottawa’s Faculty of Law in 2002, after practising law in Canada with a national law firm and serving as a law clerk to the Hon. Mr. Justice John Sopinka of the Supreme Court of Canada. She is now an Associate Professor at the Faculty of Law, where she teaches “Mental Health Law and Neuroethics,” as well as “Medical-Legal Issues,” and “Tort Law.” She holds a reading group for students interested in ethico-legal questions raised by emerging research in cognitive neuroscience and behavioural genetics, as well as issues in mental health law. She has also taught a graduate level course called “Technoprudence,” which addresses the philosophy of law and technology. Jennifer Chandler researches and writes about the legal and ethical aspects of advances in biomedical science and technology, with particular interest in neuroethics, organ donation and regenerative medicine. Recently she has written on the legal implications of advances in neurotherapies and neuro-imaging technologies, regulatory policy related to medical practices such as organ donation and transplantation, and the ethics and law of scientific inquiry.
Please RSVP here .